Potency ratios of morphine and morphine-6β-glucuronide analgesia elicited from the periaqueductal gray, locus coeruleus or rostral ventromedial medulla of rats

Brain Research

Volumn 799, Issue 2, 1998, Pages 329-333

  Krzanowska, Eliza K ^a   Rossi, Grace C ^b   Pasternak, Gavril W ^b   Bodnar, Richard J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Analgesia; Locus coeruleus; Morphine; Morphine 6 glucuronide; Pain; Periaqueductal gray; Rostral ventromedial medulla

Indexed keywords

MORPHINE; MORPHINE 6 GLUCURONIDE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; JUMPING; LOCUS CERULEUS; MALE; MEDULLA OBLONGATA; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCUS COERULEUS; MALE; MEDULLA OBLONGATA; MORPHINE; MORPHINE DERIVATIVES; NOCICEPTORS; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032551585     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00520-4     Document Type: Article

References (29)

1. F.V. Abbott, R.M. Palmour, Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats, Life Sci. 43 (1988) 1685-1695.
2. R.J. Bodnar, D. Paul, G.W. Pasternak, Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus: studies with the partial mu-1 agonist ethylketocyclazocine, Brain Res. 558 (1991) 224-230.
3. R.J. Bodnar, C.L. Williams, S.J. Lee, G.W. Pasternak, Role of mu1 opiate receptors in supraspinal opiate analgesia: a microinjection study, Brain Res. 447 (1988) 25-34.
4. G.P. Brown, K. Yang, M.A. King, G.C. Rossi, L. Leventhal, A. Chang, G.W. Pasternak, 3-methoxynaltrexone, a selective heroin/morphine-6β-glucuronide antagonist, FEBS Lett. 412 (1997) 35-38.
5. F.E. D'Amour, D.L. Smith, A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther. 72 (1941) 74-79.
6. W.O. Evans, A new technique for the investigation of some analgesic drugs on a reflexive behavior in the rat, Psychopharmacology 2 (1961) 318-325.
7. F.G. Fang, H.L. Fields, N.M. Lee, Action at the mu receptor is sufficient to explain supraspinal analgesic effect of opiates, J. Pharmacol. Exp. Ther. 238 (1986) 1039-1044.
8. B. Frances, R. Gout, B. Monsarrat, J. Cros, J. Zajac, Further evidence that morphine-6-glucuronide is a more potent opioid agonist than morphine, J. Pharmacol. Exp. Ther. 262 (1992) 25-31.
9. Y. Jacquet, A. Lajtha, Morphine action at central nervous system sites in rat: analgesia or hyperalgesia depending on site and dose, Science 182 (1973) 490-491.
10. T.S. Jensen, T.L. Yaksh III, Comparison of antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique, Brain Res. 372 (1986) 301-312.
11. J.M. Kiefel, M.L. Cooper, R.J. Bodnar, Inhibition of mesencephalic morphine analgesia by methysergide in the medial ventral medulla of rats, Physiol. Behav. 51 (1992) 201-205.
12. J.M. Kiefel, M.L. Cooper, R.J. Bodnar, Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia, Brain Res. 597 (1992) 331-338.
13. J.M. Kiefel, G.C. Rossi, R.J. Bodnar, Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats, Brain Res. 624 (1993) 151-160.
14. G.W. Pasternak, R.J. Bodnar, J.A. Clark, C.E. Inturrisi, Morphine-6-glucuronide, a potent mu agonist, Life Sci. 41 (1987) 2845-2849.
15. G.W. Pasternak, K.M. Standifer, Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology, Trends Pharmacol. Sci. 16 (1995) 344-350.
16. D. Paul, K.M. Standifer, C.E. Inturrisi, G.W. Pasternak, Pharmacological characterization of morphine-6beta-glucuronide, a very potent morphine metabolite, J. Pharmacol. Exp. Ther. 251 (1989) 477-483.
17. G.C. Rossi, G.P. Brown, L. Leventhal, K. Yang, G.W. Pasternak, Novel receptor mechanisms for heroin and morphine-6B-glucuronide analgesia, Neurosci. Lett. 216 (1996) 1-4.
18. G.C. Rossi, L. Leventhal, Y.-X. Pan, J. Cole, W. Su, R.J. Bodnar, G.W. Pasternak, Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception, J. Pharmacol. Exp. Ther. 281 (1997) 109-114.
19. G.C. Rossi, Y.X. Pan, G.P. Brown, G.W. Pasternak, Antisense mapping the MOR-1 receptor: evidence for alternative splicing and a novel morphine-6Beta-glucuronide receptor, FEBS Lett. 369 (1995) 192-196.
20. G.C. Rossi, G.W. Pasternak, R.J. Bodnar, Synergistic brainstem interactions for morphine analgesia, Brain Res. 624 (1993) 171-180.
21. G.C. Rossi, G.W. Pasternak, R.J. Bodnar, Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla, Brain Res. 665 (1994) 85-93.
22. G.C. Rossi, K.M. Standifer, G.W. Pasternak, Differential blockade of morphine and morphine-6B-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats, Neurosci. Lett. 198 (1995) 99-102.
23. K. Shimomura, O. Kamata, S. Ueki, S. Ida, K. Oguri, H. Yoshimura, H. Tsukamoto, Analgesic effects of morphine glucuronides, Tokohu J. Exp. Med. 105 (1971) 45-52.
24. D.J. Smith, J.M. Perotti, T. Crisp, M.E.Y. Cabral, J.T. Long, J.N. Scalziti, The mu receptor is responsible for descending pain inhibition originating in the periaqueductal gray region of the rat brain, Eur. J. Pharmacol. 156 (1988) 47-54.
25. M. Spinella, M.L. Cooper, R.J. Bodnar, Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats, Pain 64 (1996) 545-552.
26. M. Spinella, L.A. Schaefer, R.J. Bodnar, Ventral medullary mediation of mesencephalic morphine analgesia by muscarinic and nico-tinic cholinergic receptor antagonists in rats, Analgesia 3 (1997) 119-130.
27. A.F. Sullivan, H.J. McQuay, D. Bailey, A.H. Dickenson, The spinal antinociceptive actions of morphine metabolites, morphine-6-glucuronide and normorphine in the rat, Brain Res. 482 (1989) 219-224.
28. H. vanPraag, H. Frenk, The role of glutamate in opiate descending inhibition of nociceptive spinal reflexes, Brain Res. 524 (1990) 101-105.
29. T.L. Yaksh, J.A. Yeung, T.A. Rudy, Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observations of differential effects within the periaqueductal gray, Brain Res. 114 (1976) 83-103.